NDC 17856-1172 – Lithium
Lithium Citrate 8 meq/5mL · Solution · Oral
Product NDC17856-1172
Product details
- Brand name
- Lithium
- Generic name
- Lithium
- Labeler
- Atlantic Biologicals Corp.
- Dosage form
- Solution
- Route
- Oral
- Marketing category
- ANDA · ANDA218036
- Marketed since
- November 9, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- Mood Stabilizer
Active ingredients
- Lithium Citrate 8 meq/5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 17856-1172-1 | 30 SYRINGE in 1 CASE (17856-1172-1) / 15 mL in 1 SYRINGE | Aug 24, 2026 |
Other Lithium products
- 72888-172 Lithium Citrate 8 meq/5mL · Solution · Advagen Pharma Ltd
- 0121-1027 Lithium Citrate 8 meq/5mL · Solution · PAI Holdings, LLC dba PAI Pharma
- 0121-4027 Lithium Citrate 8 meq/5mL · Solution · PAI Holdings, LLC dba PAI Pharma
- 68094-077 Lithium Citrate 8 meq/5mL · Solution · Precision Dose, Inc.
- 70518-4227 Lithium Citrate 8 meq/5mL · Solution · REMEDYREPACK INC.
- 71656-072 Lithium Citrate 8 meq/5mL · Solution · Saptalis Pharmaceuticals, LLC
- 60986-1019 Lithium Bromide 3 [hp_X]/mL · Liquid · Marco Pharma International LLC.